AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2003
Sep 24, 2003
29777_dirs_2003-09-24_15b7c61b-82de-4d1a-9485-fe3cff1bbff7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2003-09-15
Reporting Person: NEMMERS JOSEPH M (Senior Vice President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 39901 | Direct |
| Common shares without par value | 10274 | Indirect |
| Common shares without par value | 328 | Indirect |
| Common shares without par value | 328 | Indirect |
| Common shares without par value | 275 | Indirect |
| Common shares without par value | 269 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option (right to buy) | $21.85 | 2006-02-08 | Common shares (6358) | Direct | |
| Option (right to buy) | $29.19 | 2007-02-13 | Common shares (3946) | Direct | |
| Option (right to buy) | $37.00 | 2008-02-12 | Common shares (4070) | Direct | |
| Option (right to buy) | $37.00 | 2008-02-12 | Common shares (2930) | Direct | |
| Option (right to buy) | $45.22 | 2009-02-11 | Common shares (4885) | Direct | |
| Option (right to buy) | $45.22 | 2009-02-11 | Common shares (2515) | Direct | |
| Option (right to buy) | $34.70 | 2010-02-10 | Common shares (2881) | Direct | |
| Option (right to buy) | $48.36 | 2011-02-08 | Common shares (10667) | Direct | |
| Option (right to buy) | $48.36 | 2011-02-08 | Common shares (5333) | Direct | |
| Option (right to buy) | $55.375 | 2011-12-02 | Common shares (3334) | Direct | |
| Option (right to buy) | $55.375 | 2011-12-02 | Common shares (3333) | Direct | |
| Option (right to buy) | $55.375 | 2011-12-02 | Common shares (3333) | Direct | |
| Option (right to buy) | $57.06 | 2012-02-14 | Common shares (13334) | Direct | |
| Option (right to buy) | $57.06 | 2012-02-14 | Common shares (13333) | Direct | |
| Option (right to buy) | $57.06 | 2012-02-14 | Common shares (13333) | Direct | |
| Option (right to buy) | $54.58 | 2004-04-28 | Common shares (719) | Direct | |
| Option (right to buy) | $54.58 | 2005-04-27 | Common shares (1863) | Direct | |
| Option (right to buy) | $54.58 | 2006-02-08 | Common shares (1476) | Direct | |
| Option (right to buy) | $54.58 | 2007-02-13 | Common shares (2980) | Direct | |
| Option (right to buy) | $54.58 | 2010-02-10 | Common shares (3568) | Direct | |
| Option (right to buy) | $38.73 | 2012-06-27 | Common shares (6500) | Direct | |
| Option (right to buy) | $38.73 | 2012-06-27 | Common shares (6500) | Direct | |
| Option (right to buy) | $38.73 | 2012-06-27 | Common shares (6500) | Direct | |
| Option (right to buy) | $43.78 | 2010-02-10 | Common shares (2027) | Direct | |
| Option (right to buy) | $35.36 | 2013-02-13 | Common shares (20000) | Direct | |
| Option (right to buy) | $35.36 | 2013-02-13 | Common shares (20000) | Direct | |
| Option (right to buy) | $35.36 | 2013-02-13 | Common shares (20000) | Direct | |
| Option (right to buy) | $43.82 | 2010-02-10 | Common shares (457) | Direct |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of September 19, 2003
F2: Reporting person disclaims beneficial ownership of all securities held by his sons.
F3: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement o ption feature, in a transaction exempt from Section 16(b) under Rule 16b-3.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Earnings Release
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25